Enlivex

ENLVNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$35.011 M

$2.08 +5.05%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

$1.24B

#331 by earnings

Shares outstanding

237,381,498

Latest filing cover page

P/E ratio

0.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#369Serina TherapeuticsSER$36.0M
#370BeyondSpringBYSI$35.8M
#371EnlivexENLV$35.0M
#372Quantum CyberQUCY$32.8M
#373BriaCell TherapeuticsBCTX$31.7M

Where these numbers come from

Share counts and financials for Enlivex are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.